Search

The slow kinetic process of the oxygen evolution reaction (OER) and poor electrochemical stability in acidic environments of electrocatalysts seriously restrict the efficiency of hydrogen production from proton exchange membrane water electrolyzers (PEMWEs). In recent years, developing corrosion-resistant and redox-active doped TiO2 with heterogeneous atoms has become an effective strategy to address this challenge. However, most of the reported studies only explore single-element doped TiO2-supported catalysts, and there are few reports comparing the doping effects of various elements at the experimental level, which is crucial for screening high-performance OER electrocatalysts. In this work, seven different metal elements M (M = V, Mn, Fe, Ni, Cu, Nb, W) are selected for doping anatase TiO2 with the same molar ratio (M/Ti) and combined with IrO2 nanoparticles to form M-doped TiO2-supported IrO2 (M–TiO2@IrO2) electrocatalysts. Electrochemical OER activity and stability results indicate that W–TiO2@IrO2 exhibits the best performance among all these catalysts in terms of comprehensively regulating the conductivity of TiO2 and the activity and stability of IrOx within the range of experimental design in this work, which originates from the appropriate energy band structure obtained through W doping, optimizing the intrinsic conductivity of the support and interfacial electronic structure between the metal oxide and support. [ABSTRACT FROM AUTHOR]

Bacillus subtilis, as a biocontrol bacterium, possess a variety of biological functions and the capacity to control plant pathogens. Iturin A is a biosurfactant with broad‐spectrum antifungal activity produced by fermentation of B. subtilis. In this study, the dynamic parameters of solid‐state fermentation (SSF) and submerged fermentation (SMF) of Bacillus velezensis ND were compared, and a method for producing iturin A with a yield of 12.46 g/kg utilizing SSF was proposed. It has significant advantages over SMF and has the highest yield of all previously reported studies. B. velezensis ND also contains protease activity, cellulase activity, iron‐carrying activity, the ability to synthesis 3‐indoleacetic acid (IAA), fixation nitrogen, and degrade phosphorus. In cotton pot experiments, it can effectively increase cotton growth and minimize Verticillium wilt. This strain's superior fermentation efficiency, biological function, and biocontrol ability are sufficient to demonstrate its promise for the development and use of biocontrol agents. [ABSTRACT FROM AUTHOR]

Breast cancer (BrCa) ranks as the most prevalent malignant neoplasm affecting women worldwide. The expression of programmed death-ligand 1 (PD-L1) in BrCa has recently emerged as a biomarker for immunotherapy response, but traditional immunohistochemistry (IHC)-based methods are hindered by spatial and temporal heterogeneity. Noninvasive and quantitative PD-L1 imaging using appropriate radiotracers can serve to determine PD-L1 expression in tumors. This study aims to demonstrate the viability of PET imaging with 64 Cu-labeled Durvalumab (abbreviated as Durva) to assess PD-L1 expression using a murine xenograft model of breast cancer. Durvalumab, a human IgG1 monoclonal antibody against PD-L1, was assessed for specificity in vitro in two cancer cell lines (MDA-MB-231 triple-negative breast cancer cell line and AsPC-1 pancreatic cancer cell line) with positive and negative PD-L1 expression by flow cytometry. Next, we performed the in vivo evaluation of 64 Cu-NOTA-Durva in murine models of human breast cancer by PET imaging and ex vivo biodistribution. Additionally, mice bearing AsPC-1 tumors were employed as a negative control. Tumor uptake was quantified based on a 3D region-of-interest (ROI) analysis of the PET images and ex vivo biodistribution measurements, and the results were compared against conventional IHC testing. The radiotracer uptake was evident in MDA-MB-231 tumors and showed minimal nonspecific binding, corroborating IHC-derived results. The results of the biodistribution showed that the MDA-MB-231 tumor uptake of 64 Cu-NOTA-Durva was much higher than 64 Cu-NOTA-IgG (a nonspecific radiolabeled IgG). In Conclusion, 64 Cu-labeled Durvalumab PET/CT imaging offers a promising, noninvasive approach to evaluate tumor PD-L1 expression., Competing Interests: Weibo Cai declares conflict of interest with the following corporations: Actithera, Inc., Portrai, Inc., rTR Technovation Corporation, Four Health Global Pharmaceuticals Inc., and POP Biotechnologies, Inc., (AJNMMI Copyright © 2024.)

In recent years, there have been significant innovations in the development of nanoparticle-based vaccines and vaccine delivery systems. For the purposes of both design and evaluation, these nanovaccines are imaged using the wealth of understanding established around medical imaging of nanomaterials. An important insight to the advancement of the field of nanovaccines can be given by an analysis of the design rationale of an imaging platform, as well as the significance of the information provided by imaging. Nanovaccine imaging strategies can be categorized by the imaging modality leveraged, but it is also worth understanding the superiority or convenience of a given modality over others in a given context of a particular nanovaccine. The most important imaging modalities in this endeavor are optical imaging including near-infrared fluorescence imaging (NIRF), emission tomography methods such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) with or without computed tomography (CT) or magnetic resonance (MR), the emerging magnetic particle imaging (MPI), and finally, multimodal applications of imaging which include molecular imaging with magnetic resonance imaging (MRI) and photoacoustic (PA) imaging. One finds that each of these modalities has strengths and weaknesses, but optical and PET imaging tend, in this context, to be currently the most accessible, convenient, and informative modalities. Nevertheless, an important principle is that there is not a one-size-fits-all solution, and that the specific nanovaccine in question must be compatible with a particular imaging modality. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease., (© 2022 Wiley Periodicals LLC.)